ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

Longer Awards, Annual Recompetition considered For “CCOP 3;” Concept to DCPC Board In January

July 15, 1988

UCLA Forms Environmental Genomics Program

March 14, 2003

AACI’s “12 Tasks” Outlined to Board

March 28, 1975

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988